Loading insider details...
Beta
Latest Form 4 (Oct 13, 2026): Grant/Award of 200,000 LBRX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 13, 2026 | LB PHARMACEUTICALS INC (LBRX) | Grant/Award | 200,000 | n/a |
| Mar 3, 2026 | Aurinia Pharmaceuticals Inc. (AUPH) | Grant/Award | 57,229 | n/a |
| Feb 23, 2026 | Aurinia Pharmaceuticals Inc. (AUPH) | Tax Withholding | 32,424 | $466.9K |
| Jan 5, 2026 | Aurinia Pharmaceuticals Inc. (AUPH) | Grant/Award | 49,038 | n/a |
| Mar 5, 2025 | Aurinia Pharmaceuticals Inc. (AUPH) | Grant/Award | 81,457 | n/a |
| Mar 7, 2024 | Aurinia Pharmaceuticals Inc. (AUPH) | Sale | 34,811 | $194.9K |
| Feb 22, 2024 | Aurinia Pharmaceuticals Inc. (AUPH) | Grant/Award | 196,153 | n/a |
| Mar 6, 2023 | Aurinia Pharmaceuticals Inc. (AUPH) | Grant/Award | 229,421 | n/a |
| Apr 4, 2022 | Avalo Therapeutics, Inc. (AVTX) | Grant/Award | 20,239 | n/a |
| Mar 4, 2022 | Aurinia Pharmaceuticals Inc. (AUPH) | Grant/Award | 8,500 | n/a |